| Nome |
# |
|
Randomized Controlled Trials and real life studies. Approaches and methodologies: a clinical point of view, file e3ad8916-f1c5-da0e-e053-3705fe0a2b96
|
7.866
|
|
Assessing and accessing the small airways; implications for asthma management, file e3ad8916-f1b2-da0e-e053-3705fe0a2b96
|
1.047
|
|
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS, file e3ad8917-a8b4-da0e-e053-3705fe0a2b96
|
675
|
|
Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD, file e3ad8916-d369-da0e-e053-3705fe0a2b96
|
614
|
|
Effects of exercise training on airway responsiveness and airway cells in healthy subjects, file e3ad8915-d561-da0e-e053-3705fe0a2b96
|
555
|
|
Early Lung Function Abnormalities in Acromegaly., file e3ad8917-a777-da0e-e053-3705fe0a2b96
|
508
|
|
Relationship between specific serum IgE to Ascaris lumbricoides and onset of respiratory symptoms in Bangladesh immigrants., file e3ad8919-35dc-da0e-e053-3705fe0a2b96
|
448
|
|
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?, file e3ad8917-ab16-da0e-e053-3705fe0a2b96
|
364
|
|
An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly, file e3ad8919-f935-da0e-e053-3705fe0a2b96
|
348
|
|
Fluticasone propionate/formoterol: A fixed-combination therapy with flexible dosage, file e3ad8916-eb09-da0e-e053-3705fe0a2b96
|
331
|
|
BMI can influence adult males' and females' airway hyperresponsiveness differently, file e3ad8916-f1b4-da0e-e053-3705fe0a2b96
|
305
|
|
The impact of age on prevalence of positive skin prick tests and specific IgE tests, file e3ad8919-be13-da0e-e053-3705fe0a2b96
|
291
|
|
Commentaries on Viewpoint: Airway smooth muscle and airway hyperresponsiveness in human asthma: have we chased the wrong horse?, file e3ad8916-f1a5-da0e-e053-3705fe0a2b96
|
263
|
|
Serum low density lipoprotein subclasses in asthma, file e3ad8919-be0a-da0e-e053-3705fe0a2b96
|
258
|
|
The airway response to deep inspirations decreases with COPD severity and is associated with airway distensibility assessed by computed tomography, file e3ad8919-e4a8-da0e-e053-3705fe0a2b96
|
243
|
|
Do GOLD stages of COPD severity really correspond to differences in health status?, file e3ad891a-1ff2-da0e-e053-3705fe0a2b96
|
236
|
|
Prevalence of arterial hypertension and characteristics of nocturnal blood pressure profile of asthma patients according to therapy and severity of the disease: The bada study, file e3ad8923-10b4-da0e-e053-3705fe0a2b96
|
224
|
|
Dynamic hyperinflation during the 6-min walk test in severely asthmatic subjects, file e3ad891e-5998-da0e-e053-3705fe0a2b96
|
222
|
|
Asthma and metabolic syndrome: Current knowledge and future perspectives., file e3ad8917-ae33-da0e-e053-3705fe0a2b96
|
220
|
|
Effetti di un programma di esercizio fisico sul grado di reattività bronchiale negli asmatici, file e3ad8916-6d78-da0e-e053-3705fe0a2b96
|
217
|
|
A Potential Link between Serum Low-Density Lipoproteins and Asthma, file e3ad8919-e0f1-da0e-e053-3705fe0a2b96
|
212
|
|
Nerve ablation after bronchial thermoplasty and sustained improvement in severe asthma, file e3ad891e-372b-da0e-e053-3705fe0a2b96
|
203
|
|
Validation of lung densitometry threshold at CT for the distinction between senile lung and emphysema in elderly subjects., file e3ad8919-f2da-da0e-e053-3705fe0a2b96
|
201
|
|
Why chronic obstructive pulmonary disease patients get so short of breath with limited activity, file e3ad8916-d428-da0e-e053-3705fe0a2b96
|
200
|
|
Effects of chronic airway disease on health status of geriatric patients, file e3ad8919-e1d5-da0e-e053-3705fe0a2b96
|
199
|
|
The contribution of small-Airway abnormalities in chronic obstructive pulmonary disease clinical manifestations: More than a functional issue, file e3ad891e-97b4-da0e-e053-3705fe0a2b96
|
198
|
|
Asthma Control: The Right Inhaler for the Right Patient., file e3ad8917-a773-da0e-e053-3705fe0a2b96
|
191
|
|
Arterial stiffness in symptomatic smokers with normal lung function, file e3ad891e-5b65-da0e-e053-3705fe0a2b96
|
186
|
|
Catching allergy by a simple questionnaire, file e3ad891a-1fe1-da0e-e053-3705fe0a2b96
|
183
|
|
Asthma control in elderly asthmatics. An Italian observational study, file e3ad8916-d32b-da0e-e053-3705fe0a2b96
|
177
|
|
Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives, file e3ad891e-4405-da0e-e053-3705fe0a2b96
|
174
|
|
Similar cellular composition of induced sputum in Marathon and Half-Marathon runners, file e3ad8916-6507-da0e-e053-3705fe0a2b96
|
173
|
|
Is health-related quality of life associated with upper and lower airway inflammation in asthmatics?, file e3ad8916-f1af-da0e-e053-3705fe0a2b96
|
173
|
|
A 15-year-old boy with anterior chest pain, progressive dyspnea, and subcutaneous emphysema of the neck, file e3ad8919-d5ad-da0e-e053-3705fe0a2b96
|
173
|
|
Airway remodelling assessed by sputum and high resolution computed tomography in asthma and COPD, file e3ad8919-e34f-da0e-e053-3705fe0a2b96
|
173
|
|
Eligibility of real-life patients with copd for inclusion in rcts: A commentary, file e3ad891a-e3d7-da0e-e053-3705fe0a2b96
|
165
|
|
Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma, file e3ad8928-7dba-da0e-e053-3705fe0a2b96
|
161
|
|
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement, file e3ad891d-8e6b-da0e-e053-3705fe0a2b96
|
152
|
|
The asthma-COPD overlap syndrome (ACOS): hype or reality?
That is, a curiosity for the media or an opportunity for physicians?, file e3ad8917-b10a-da0e-e053-3705fe0a2b96
|
148
|
|
The geriatric asthma: pitfalls and challenges, file e3ad8919-db26-da0e-e053-3705fe0a2b96
|
142
|
|
Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics, file e3ad891a-bdf1-da0e-e053-3705fe0a2b96
|
142
|
|
Serum Surfactant Protein D as a Marker of Asthma Severity, file e3ad891e-56ed-da0e-e053-3705fe0a2b96
|
141
|
|
Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment options, file e3ad8919-c72b-da0e-e053-3705fe0a2b96
|
139
|
|
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD, file e3ad891e-6a73-da0e-e053-3705fe0a2b96
|
136
|
|
Patient-reported outcome measures (PROMs) using the MASK-air® app in severe asthma, file e3ad8927-ca66-da0e-e053-3705fe0a2b96
|
133
|
|
Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics, file e3ad8919-bfa6-da0e-e053-3705fe0a2b96
|
126
|
|
Allergic diseases in the elderly: Biological characteristics and main immunological and non-immunological mechanisms, file e3ad891e-9606-da0e-e053-3705fe0a2b96
|
125
|
|
Early management of COPD: Where are we now and where do we go from here? a delphi consensus project, file e3ad891f-f0a8-da0e-e053-3705fe0a2b96
|
122
|
|
Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression, file e3ad8926-011e-da0e-e053-3705fe0a2b96
|
119
|
|
Effects of a structured educational intervention in moderate-to-severe elderly asthmatic subjects, file e3ad8920-210d-da0e-e053-3705fe0a2b96
|
118
|
|
Choosing wisely: Practical considerations on treatment efficacy and safety of asthma in the elderly, file e3ad891a-0f82-da0e-e053-3705fe0a2b96
|
117
|
|
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle, file e3ad891e-9c69-da0e-e053-3705fe0a2b96
|
117
|
|
Adherence to omalizumab: A multicenter “real-world” study, file e3ad8921-a1b5-da0e-e053-3705fe0a2b96
|
117
|
|
LABA/LAMA fixed-dose combinations in patients with COPD: A systematic review, file e3ad891e-9cff-da0e-e053-3705fe0a2b96
|
115
|
|
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study, file e3ad8921-cd0c-da0e-e053-3705fe0a2b96
|
101
|
|
How Effective and Safe Is Bronchial Thermoplasty in "real Life" Asthmatics Compared to Those Enrolled in Randomized Clinical Trials?, file e3ad8919-ccdf-da0e-e053-3705fe0a2b96
|
99
|
|
Disease awareness in patients with COPD: Measurement and extent, file e3ad891e-63bf-da0e-e053-3705fe0a2b96
|
98
|
|
Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone, file e3ad891a-9c2a-da0e-e053-3705fe0a2b96
|
97
|
|
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN), file e3ad8921-db9f-da0e-e053-3705fe0a2b96
|
97
|
|
Tiotropium in asthma: Back to the future of anticholinergic treatment, file e3ad891e-372e-da0e-e053-3705fe0a2b96
|
95
|
|
The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians, file e3ad8922-cc3c-da0e-e053-3705fe0a2b96
|
92
|
|
Are Asthmatics Enrolled in Randomized Trials Representative of Real-Life Outpatients?, file e3ad8917-d5a3-da0e-e053-3705fe0a2b96
|
88
|
|
Effect of age and asthma duration upon elastase and alpha1-antitrypsin levels in adult asthmatics, file e3ad8919-d787-da0e-e053-3705fe0a2b96
|
87
|
|
Correction: Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study (BMC Pulmonary Medicine (2019) 19 (171) DOI: 10.1186/s12890-019-0935-2), file e3ad8921-a661-da0e-e053-3705fe0a2b96
|
87
|
|
Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study, file e3ad8921-edb3-da0e-e053-3705fe0a2b96
|
87
|
|
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: An Italian Multicenter Study, file e3ad891e-4414-da0e-e053-3705fe0a2b96
|
84
|
|
Effects of aclidinium on determinants of COPD severity: Symptoms and quality of life, file e3ad891e-3f34-da0e-e053-3705fe0a2b96
|
82
|
|
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life, file e3ad8925-eecc-da0e-e053-3705fe0a2b96
|
82
|
|
Asthma in the elderly: A different disease?, file e3ad8919-331c-da0e-e053-3705fe0a2b96
|
76
|
|
Chronic obstructive lung disease “expert system”: Validation of a predictive tool for assisting diagnosis, file e3ad891e-68c6-da0e-e053-3705fe0a2b96
|
72
|
|
Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution, file e3ad8927-ce3d-da0e-e053-3705fe0a2b96
|
71
|
|
Prioritizing care for severe asthma during SARS-CoV-2 pandemic, file e3ad8926-09fe-da0e-e053-3705fe0a2b96
|
70
|
|
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma, file e3ad8921-cdd7-da0e-e053-3705fe0a2b96
|
66
|
|
Minimal clinically important difference for asthma endpoints: An expert consensus report, file e3ad8926-1c38-da0e-e053-3705fe0a2b96
|
63
|
|
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma, file e3ad8926-17b5-da0e-e053-3705fe0a2b96
|
61
|
|
Cypress pollen: an unexpected major sensitizing agent in different regions of Italy, file e3ad8916-d2e9-da0e-e053-3705fe0a2b96
|
60
|
|
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy, file e3ad8925-fc14-da0e-e053-3705fe0a2b96
|
58
|
|
Fever and dyspnoea in a tracheostomised patient, file e3ad8925-eec8-da0e-e053-3705fe0a2b96
|
55
|
|
Airway deposition of extrafine inhaled triple therapy in patients with copd: A model approach based on functional respiratory imaging computer simulations, file e3ad8926-17b3-da0e-e053-3705fe0a2b96
|
53
|
|
Is diet partly responsible for differences in COVID-19 death rates between and within countries?, file e3ad8926-1c3a-da0e-e053-3705fe0a2b96
|
52
|
|
Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients, file e3ad8920-dad3-da0e-e053-3705fe0a2b96
|
51
|
|
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma, file e3ad8925-3bf0-da0e-e053-3705fe0a2b96
|
50
|
|
Day and night control of copd and role of pharmacotherapy: A review, file e3ad8926-17b7-da0e-e053-3705fe0a2b96
|
50
|
|
The influence of smoking status on exhaled breath profiles in asthma and COPD patients, file e3ad8928-6c3c-da0e-e053-3705fe0a2b96
|
50
|
|
Is mild asthma in real life always in the Green Zone?, file e3ad8916-f1aa-da0e-e053-3705fe0a2b96
|
40
|
|
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments, file e3ad8928-ae5b-da0e-e053-3705fe0a2b96
|
38
|
|
Physician's mistakes in the interpretation of spirometry, file e3ad8917-cb86-da0e-e053-3705fe0a2b96
|
36
|
|
Beliefs and preferences regarding biological treatments for severe asthma, file e3ad8926-1c3c-da0e-e053-3705fe0a2b96
|
36
|
|
The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damage, file e3ad8916-d2e3-da0e-e053-3705fe0a2b96
|
35
|
|
When kidneys and lungs suffer together, file e3ad8920-497c-da0e-e053-3705fe0a2b96
|
32
|
|
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis, file e3ad8928-6acc-da0e-e053-3705fe0a2b96
|
26
|
|
COPD classification methods and informativeness on mortality: contrasting evidences, file e3ad8916-d161-da0e-e053-3705fe0a2b96
|
25
|
|
Airway distensibility by HRCT in asthmatics and COPD with comparable airway obstruction, file e3ad891d-6564-da0e-e053-3705fe0a2b96
|
25
|
|
Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT)study follow-up, file e3ad891f-f09b-da0e-e053-3705fe0a2b96
|
25
|
|
HRCT evaluation of bronchial response to deep inspiration in asthma and chronic
obstructive pulmonary disease (COPD), file e3ad8916-4b21-da0e-e053-3705fe0a2b96
|
23
|
|
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics, file e3ad8928-a1c6-da0e-e053-3705fe0a2b96
|
23
|
|
Pulmonary functional and radiological correlations of nutritional status and physical activity in systemic sclerosis, file e3ad8916-4ac4-da0e-e053-3705fe0a2b96
|
21
|
|
The COPD multi-dimensional phenotype: A new classification from the STORICO Italian observational study, file e3ad8920-19d3-da0e-e053-3705fe0a2b96
|
21
|
|
One-year evolution of symptoms and health status of the copd multi-dimensional phenotypes: Results from the follow-up of the storico observational study, file e3ad8927-ce3f-da0e-e053-3705fe0a2b96
|
21
|
|
Real-world experience with dupilumab in severe asthma: One-year data from an italian named patient program, file e3ad8927-c922-da0e-e053-3705fe0a2b96
|
18
|
| Totale |
23.265 |